Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Home testing for sleep apnea to improve well-being in patients with atrial fibrillation

Official title: National Decentral/Virtual Randomized Trial Testing Remote Sleep Apnea Evaluation in Patients With Atrial Fibrillation

Run by Herlev and Gentofte Hospital · NCT06618417 · Data updated 2026-11-12

This study is testing if home testing and treatment for sleep apnea can help people with atrial fibrillation feel better and improve their quality of life.

More Sleep Apnea trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment936 (estimated)
SponsorHerlev and Gentofte Hospital
Academic / other
Locations1 site (Hellerup)
StatusRecruiting
StartedDecember 5, 2024
Main results expectedFebruary 1, 2027
Study endsJune 30, 2027
Registry record updatedAugust 26, 2026
Trial IDNCT06618417 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include individuals with established paroxysmal or persistent atrial fibrillation who own a compatible smartphone.

Probably not a fit

Patients with advanced heart failure, previous investigations for sleep-disturbed breathing, or those who are pregnant may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial aims to evaluate whether home-based testing for sleep apnea can enhance the well-being of individuals diagnosed with atrial fibrillation. Approximately 936 participants will be randomly assigned to either receive sleep apnea testing and treatment or not receive any testing. The study will track participants' well-being and heart-related symptoms through a mobile app over 18 weeks, measuring quality of life improvements using the Atrial Fibrillation Effect on QualiTy-of-life (AFEQT) questionnaire. The hypothesis is that those tested and treated for sleep apnea will show a significant improvement in their quality of life scores compared to those who are not tested.

Why it matters

Potential benefit: If successful, this approach could lead to improved quality of life and health outcomes for patients with atrial fibrillation by effectively managing sleep apnea.

How similar studies have gone: Other studies have indicated the importance of managing sleep apnea in patients with atrial fibrillation, suggesting that this approach may yield beneficial results.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Established paroxysmal or persistent AF diagnosis
* Owning a compatible smartphone
* 18 years or older

Exclusion Criteria:

* Previous investigation for sleep-disturbed breathing
* Advanced heart failure (left ventricular dysfunction and NYHA III/IV)
* Occupational driver licenses
* Pregnancy
* Doxazosin or Terazosin treatment (alpha-adrenergic antagonists)
* Peripheral arterial disease with daily intermittent claudication

Where it's running

  • Herlev-Gentofte Hospital
    Hellerup, Denmark
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.